| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.32 | 0.02 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |